Lapiferin protects against H1N1 virus-induced pulmonary inflammation by negatively regulating NF-kB signaling
- PMID: 32901688
- PMCID: PMC7485324
- DOI: 10.1590/1414-431X20209183
Lapiferin protects against H1N1 virus-induced pulmonary inflammation by negatively regulating NF-kB signaling
Abstract
H1N1 virus-induced excessive inflammatory response contributes to severe disease and high mortality rates. There is currently no effective strategy against virus infection in lung. The present study evaluated the protective roles of a natural compound, lapiferin, in H1N1 virus-induced pulmonary inflammation in mice and in cultured human bronchial epithelial cells. Initially, Balb/C mice were grouped as Control, H1N1 infection (intranasally infected with 500 plaque-forming units of H1N1 virus), lapiferin (10 mg/kg), and H1N1+lapiferin (n=10/group). Lung histology, expression of inflammatory factors, and survival rates were assessed after 14 days of exposure. Administration of lapiferin significantly alleviated the virus-induced inflammatory infiltrate in lung tissues. Major pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, were decreased at both mRNA and protein levels by lapiferin administration in the lung homogenate. Lapiferin also reduced inflammatory cell numbers in bronchoalveolar fluid. Mechanistically, lapiferin suppressed the transcriptional activity and protein expression of NF-κB p65, causing inhibition on NF-κB signaling. Pre-incubation of human bronchial epithelial cells with an NF-κB signaling specific activator, ceruletide, significantly blunted lapiferin-mediated inhibition of pro-inflammatory cytokines secretion in an air-liquid-interface cell culture experiment. Activation of NF-κB signaling also blunted lapiferin-ameliorated inflammatory infiltrate in lungs. These results suggested that lapiferin was a potent natural compound that served as a therapeutic agent for virus infection in the lung.
Figures
Similar articles
-
Polygalasaponin F treats mice with pneumonia induced by influenza virus.Inflammopharmacology. 2020 Feb;28(1):299-310. doi: 10.1007/s10787-019-00633-1. Epub 2019 Aug 24. Inflammopharmacology. 2020. PMID: 31446589 Free PMC article.
-
San Wu Huangqin decoction regulates inflammation and immune dysfunction induced by influenza virus by regulating the NF-κB signaling pathway in H1N1-infected mice.J Ethnopharmacol. 2021 Jan 10;264:112800. doi: 10.1016/j.jep.2020.112800. Epub 2020 Mar 27. J Ethnopharmacol. 2021. PMID: 32224195
-
Flavonoids from Houttuynia cordata attenuate H1N1-induced acute lung injury in mice via inhibition of influenza virus and Toll-like receptor signalling.Phytomedicine. 2020 Feb;67:153150. doi: 10.1016/j.phymed.2019.153150. Epub 2019 Dec 16. Phytomedicine. 2020. PMID: 31958713
-
Leonurine protects against influenza A virus infection-induced pneumonia in mice.Pathog Dis. 2021 Sep 23;79(7):ftab045. doi: 10.1093/femspd/ftab045. Pathog Dis. 2021. PMID: 34543397
-
Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice.Crit Care. 2013 Dec 27;17(6):R301. doi: 10.1186/cc13171. Crit Care. 2013. PMID: 24373231 Free PMC article.
Cited by
-
Functional Analysis of the Cathepsin D Gene Response to SGIV Infection in the Orange-Spotted Grouper, Epinephelus coioides.Viruses. 2022 Jul 29;14(8):1680. doi: 10.3390/v14081680. Viruses. 2022. PMID: 36016302 Free PMC article.
-
Glycyrrhizin alleviates BoAHV-1-induced lung injury in guinea pigs by inhibiting the NF-κB/NLRP3 Signaling pathway and activating the Nrf2/HO-1 Signaling pathway.Vet Res Commun. 2024 Aug;48(4):2499-2511. doi: 10.1007/s11259-024-10436-7. Epub 2024 Jun 12. Vet Res Commun. 2024. PMID: 38865040
References
-
- Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010;362:1708–1719. doi: 10.1056/NEJMra1000449. - DOI - PubMed
-
- Dananché C, Sánchez Picot V, Bénet T, Messaoudi M, Chou M, Wang J, et al. Burden of influenza in less than 5-year-old children admitted to hospital with pneumonia in developing and emerging countries: a descriptive, multicenter study. Am J Trop Med Hyg. 2018;98:1805–1810. doi: 10.4269/ajtmh.17-0494. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
